• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康需求评估:2016-2032 年墨西哥无社会保障人群 2 型糖尿病继发慢性肾脏病。

Health Needs Assessment: Chronic Kidney Disease Secondary to Type 2 Diabetes Mellitus in a Population without Social Security, Mexico 2016-2032.

机构信息

Centro de Estudios Económicos y Sociales en Salud, Hospital Infantil de México Federico Gómez, Instituto Nacional de Salud, Mexico City 06720, Mexico.

Dirección de Prestaciones Económicas y Sociales, Instituto Mexicano del Seguro Social, Mexico City 06600, Mexico.

出版信息

Int J Environ Res Public Health. 2022 Jul 25;19(15):9010. doi: 10.3390/ijerph19159010.

DOI:10.3390/ijerph19159010
PMID:35897379
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9332051/
Abstract

Health needs assessment is a relevant tracer of planning process of healthcare programs. The objective is to assess the health needs of chronic kidney disease (CKD) secondary to type 2 diabetes mellitus (T2 DM) in a population without social security in Mexico. The study design was a statistical simulation model based on data at the national level of Mexico. A stochastic Markov model was used to simulate the progression from diabetes to CKD. The time horizon was 16 years. The results indicate that in 2022, kidney damage progression and affectation in the diabetic patient cohort will be 34.15% based on the time since T2 DM diagnosis. At the end of the 16-year period, assuming that the model of care remains unchanged, early renal involvement will affect slightly more than twice as many patients (118%) and cases with macroalbuminuria will triple (228%). The need for renal replacement therapy will more than double (169%). Meanwhile, deaths associated with cardiovascular risk will more than triple (284%). We concluded that the clinical manifestations of patients with CKD secondary to T2 DM without social security constitute a double challenge. The first refers to the fact that the greatest health need is early care of CKD, and the second is the urgent need to address cardiovascular risk in order to reduce deaths in the population at risk.

摘要

健康需求评估是医疗保健计划规划过程的一个重要指标。本研究旨在评估墨西哥无社会保障人群中 2 型糖尿病(T2DM)继发慢性肾脏病(CKD)的健康需求。研究设计基于墨西哥国家层面的数据,采用统计模拟模型。使用随机马尔可夫模型来模拟糖尿病向 CKD 的进展。时间范围为 16 年。结果表明,2022 年,基于 T2DM 诊断后的时间,糖尿病患者队列的肾脏损伤进展和影响将达到 34.15%。在 16 年的时间结束时,假设护理模式保持不变,早期肾脏受累将影响略多于两倍的患者(118%),且伴有大量白蛋白尿的病例将增加两倍(228%)。需要肾脏替代治疗的患者将增加一倍以上(169%)。同时,与心血管风险相关的死亡人数将增加两倍以上(284%)。我们得出结论,无社会保障的 T2DM 继发 CKD 患者的临床表现构成了双重挑战。第一个挑战是最大的健康需求是早期 CKD 的护理,第二个挑战是迫切需要解决心血管风险,以降低高危人群的死亡人数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036d/9332051/1b3dd385ba6e/ijerph-19-09010-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036d/9332051/7896c530feea/ijerph-19-09010-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036d/9332051/01ebaa75f539/ijerph-19-09010-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036d/9332051/1b3dd385ba6e/ijerph-19-09010-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036d/9332051/7896c530feea/ijerph-19-09010-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036d/9332051/01ebaa75f539/ijerph-19-09010-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036d/9332051/1b3dd385ba6e/ijerph-19-09010-g003.jpg

相似文献

1
Health Needs Assessment: Chronic Kidney Disease Secondary to Type 2 Diabetes Mellitus in a Population without Social Security, Mexico 2016-2032.健康需求评估:2016-2032 年墨西哥无社会保障人群 2 型糖尿病继发慢性肾脏病。
Int J Environ Res Public Health. 2022 Jul 25;19(15):9010. doi: 10.3390/ijerph19159010.
2
Incident Type 2 Diabetes Among Individuals With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.慢性肾脏病患者中 2 型糖尿病的发病情况:来自慢性肾功能不全队列(CRIC)研究的结果。
Am J Kidney Dis. 2019 Jan;73(1):72-81. doi: 10.1053/j.ajkd.2018.06.017. Epub 2018 Sep 1.
3
Diagnostic Yield of Population-Based Screening for Chronic Kidney Disease in Low-Income, Middle-Income, and High-Income Countries.基于人群的慢性肾脏病筛查在低收入、中等收入和高收入国家的诊断收益。
JAMA Netw Open. 2021 Oct 1;4(10):e2127396. doi: 10.1001/jamanetworkopen.2021.27396.
4
Study protocol: rationale and design of the community-based prospective cohort study of kidney function and diabetes in rural New Mexico, the COMPASS study.研究方案:新墨西哥州农村地区肾脏功能与糖尿病社区前瞻性队列研究(COMPASS研究)的原理与设计
BMC Nephrol. 2018 Feb 27;19(1):47. doi: 10.1186/s12882-018-0842-4.
5
Predictors of chronic kidney disease survival in type 2 diabetes: a 12-year retrospective cohort study utilizing estimated glomerular filtration rate.利用估算肾小球滤过率评估 2 型糖尿病慢性肾脏病患者的生存预测因素:一项为期 12 年的回顾性队列研究
Sci Rep. 2024 Apr 19;14(1):9014. doi: 10.1038/s41598-024-58574-x.
6
The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis.新诊断糖尿病患者中与慢性肾脏病相关的不同心血管疾病发病率的风险轨迹:倾向评分匹配队列分析。
Cardiovasc Diabetol. 2021 Apr 24;20(1):86. doi: 10.1186/s12933-021-01279-6.
7
Separate and joint effects of diabetes mellitus and chronic kidney disease on the risk of acute coronary syndrome: a population-based cohort study.糖尿病和慢性肾脏病对急性冠状动脉综合征风险的单独及联合影响:一项基于人群的队列研究。
Medicine (Baltimore). 2014 Dec;93(28):e261. doi: 10.1097/MD.0000000000000261.
8
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
9
The frailty risk trajectory associated with kidney and cardiovascular morbidities among patients with incident diabetes: A population-based study.初诊糖尿病患者的肾脏和心血管合并症相关脆弱风险轨迹:一项基于人群的研究。
Atherosclerosis. 2022 Oct;358:60-67. doi: 10.1016/j.atherosclerosis.2022.06.1010. Epub 2022 Jun 14.
10
Risk factors of chronic kidney disease among type 2 diabetic patients with longer duration of diabetes.2 型糖尿病患者中糖尿病病程较长者发生慢性肾脏病的危险因素。
Front Endocrinol (Lausanne). 2022 Dec 9;13:1079725. doi: 10.3389/fendo.2022.1079725. eCollection 2022.

引用本文的文献

1
External validation of a minimal-resource model to predict reduced estimated glomerular filtration rate in people with type 2 diabetes without diagnosis of chronic kidney disease in Mexico: a comparison between country-level and regional performance.墨西哥 2 型糖尿病患者中未诊断慢性肾脏病患者估算肾小球滤过率降低的最小资源模型的外部验证:国家级和地区级表现的比较。
Front Endocrinol (Lausanne). 2024 Mar 22;15:1253492. doi: 10.3389/fendo.2024.1253492. eCollection 2024.
2
Correction: Martínez-Valverde et al. Health Needs Assessment: Chronic Kidney Disease Secondary to Type 2 Diabetes Mellitus in a Population without Social Security, Mexico 2016-2032. 2022, , 9010.更正:马丁内斯 - 瓦尔韦德等人。健康需求评估:墨西哥2016 - 2032年无社会保障人群中2型糖尿病继发的慢性肾脏病。2022年,,9010。
Int J Environ Res Public Health. 2023 Feb 28;20(5):4367. doi: 10.3390/ijerph20054367.

本文引用的文献

1
Evolution of renal replacement therapy in Mexico in the last 10 years.过去十年墨西哥肾脏替代疗法的发展历程。
Nefrologia (Engl Ed). 2021 Jan-Feb;41(1):82-83. doi: 10.1016/j.nefroe.2020.02.005. Epub 2021 Mar 8.
2
Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline.慢性肾脏病中的糖尿病管理:2020KDIGO 临床实践指南概要。
Ann Intern Med. 2021 Mar;174(3):385-394. doi: 10.7326/M20-5938. Epub 2020 Nov 10.
3
[Prevalence of diabetes and poor glycemic control in Mexico: results from Ensanut 2016.].
[墨西哥糖尿病患病率及血糖控制不佳情况:2016年全国健康与营养状况调查结果。]
Salud Publica Mex. 2020 Jan-Feb;62(1):50-59. doi: 10.21149/10752.
4
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.临床连续血糖监测数据解读目标:时间范围国际共识推荐意见。
Diabetes Care. 2019 Aug;42(8):1593-1603. doi: 10.2337/dci19-0028. Epub 2019 Jun 8.
5
Sex hormones and their influence on chronic kidney disease.性激素及其对慢性肾脏病的影响。
Curr Opin Nephrol Hypertens. 2019 Jan;28(1):1-9. doi: 10.1097/MNH.0000000000000463.
6
Mortality in Patients With Chronic Renal Disease Without Health Insurance in Mexico: Opportunities for a National Renal Health Policy.墨西哥无医疗保险的慢性肾病患者的死亡率:国家肾脏健康政策的机遇
Kidney Int Rep. 2018 Jun 20;3(5):1171-1182. doi: 10.1016/j.ekir.2018.06.004. eCollection 2018 Sep.
7
Improving Global Kidney Health: International Society of Nephrology Initiatives and the Global Kidney Health Atlas.改善全球肾脏健康:国际肾脏病学会倡议和全球肾脏健康地图集。
Ann Nutr Metab. 2018;72 Suppl 2:28-32. doi: 10.1159/000488123. Epub 2018 Jun 20.
8
Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis.慢性肾脏病中的心血管疾病危险因素:系统评价和荟萃分析。
PLoS One. 2018 Mar 21;13(3):e0192895. doi: 10.1371/journal.pone.0192895. eCollection 2018.
9
US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States.美国肾脏数据系统2017年年报:美国肾脏疾病流行病学
Am J Kidney Dis. 2018 Mar;71(3 Suppl 1):A7. doi: 10.1053/j.ajkd.2018.01.002.
10
Normoalbuminuric diabetic kidney disease.正常白蛋白尿的糖尿病肾病。
Front Med. 2017 Sep;11(3):310-318. doi: 10.1007/s11684-017-0542-7. Epub 2017 Jul 18.